SCHEMBL25338317

SCHEMBL25338317

OCC1CCN1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KCNA3 P22001 1/20 0.37
CYP2D6 P10635 4/20 0.36
LMNA P02545 3/20 0.36
HRH1 P35367 2/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
CHRM2 P08172 4/20 0.36
CHRM1 P11229 4/20 0.36
CHRM3 P20309 4/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36
KCNH2 Q12809 2/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20595815 1.00 MEN1 (0.38) MEN1KMT2AKCNA3CYP2D6LMNA
SCHEMBL29182442 1.00 MEN1 (0.38) MEN1KMT2AKCNA3CYP2D6LMNA
SCHEMBL7839730 0.90 MEN1 (0.46) MEN1KMT2ACYP2D6LMNAHRH1
SCHEMBL9015291 0.90 MEN1 (0.46) MEN1KMT2ACYP2D6LMNAHRH1
SCHEMBL18040352 0.88 CYP2D6 (0.41) MEN1KMT2ACYP2D6LMNAHRH1
SCHEMBL17923208 0.88 CYP2D6 (0.41) MEN1KMT2ACYP2D6LMNAHRH1
SCHEMBL18040350 0.88 CYP2D6 (0.41) MEN1KMT2ACYP2D6LMNAHRH1
SCHEMBL29182460 0.87 CHRM2 (0.43) MEN1KMT2ACYP2D6LMNAHRH1
SCHEMBL29182446 0.87 CHRM2 (0.43) MEN1KMT2ACYP2D6LMNAHRH1
SCHEMBL29182441 0.87 CHRM2 (0.43) MEN1KMT2ACYP2D6LMNAHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260055133-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS WAVE LIFE SCIENCES LTD (SG) 2026-02-26 US disclosed
US-12428442-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2025-09-30 US disclosed
US-20240174710-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS WAVE LIFE SCIENCES LTD. (SG) 2024-05-30 US disclosed
CN-117500811-A Covalent RAS inhibitors and uses thereof 锐新医药公司 2024-02-02 CN disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
US-20220356204-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS WAVE LIFE SCIENCES LTD. (SG) 2022-11-10 US disclosed
CN-114980976-A Covalent RAS inhibitors and uses thereof 锐新医药公司 2022-08-30 CN disclosed
CN-111051281-A Compounds, compositions and methods for synthesis 波涛生命科学有限公司 2020-04-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718638-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT MEN1 1483/4885KMT2A 1427/4885KCNA3 4747/4885
US-20220356204-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS ALKBH1, DUT, RNGTT MEN1 1483/4885KMT2A 1427/4885KCNA3 4747/4885
US-12428442-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT MEN1 1483/4885KMT2A 1427/4885KCNA3 4747/4885
US-20260055133-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS NSUN2, NSUN3, NOP2 MEN1 3558/4885KMT2A 1706/4885KCNA3 4283/4885
US-20240174710-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR SYNTHESIS ALKBH1, DUT, RNGTT MEN1 1483/4885KMT2A 1427/4885KCNA3 4747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.